GlaxoSmithKline plc’s (LON:GSK) chief financial officer Simon Dingemans has decided to retire, the consumer healthcare giant said on Wednesday.
Dingemans, who joined GSK back in 2011, will officially step down from the board next May.
READ: GSK reports drop in quarterly earnings
Glaxo – which makes everything from Sensodyne toothpaste to Nicorette nicotine patches – said it will now conduct a thorough global search both internally and externally to find a replacement.
“Since joining GSK, Simon has played a very significant role in shaping the company,” said chief executive Emma Walmsley.
“I am particularly grateful for his support and partnership since I took on the role of CEO and his counsel to me as we defined our new strategy.”
GSK shares were down 0.5% at 1,465p in early afternoon trade in London.